Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Nov 30, 2023. (Total: 223474Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 7 (of 7 Records)

Query Trace: Osteonecrosis and PPARG[original query]
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.
British journal of haematology 2011 Aug 154 (4): 529-33.
Di Martino Maria T, Arbitrio Mariamena, Guzzi Pietro H, Leone Emanuela, Baudi Francesco, Piro Eugenio, Prantera Tullia, Cucinotto Iole, Calimeri Teresa, Rossi Marco, Veltri Pierangelo, Cannataro Mario, Tagliaferri Pierosandro, Tassone Pierfrances
Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy.
Leukemia & lymphoma 2017 Jun 1-6.
Kastritis Efstathios, Melea Pelagia, Bagratuni Tina, Melakopoulos Ioannis, Gavriatopoulou Maria, Roussou Maria, Migkou Magdalini, Eleutherakis-Papaiakovou Evangelos, Terpos Evangelos, Dimopoulos Meletios
Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
International journal of oral and maxillofacial surgery 2019 Aug .
Guo Z, Cui W, Que L, Li C, Tang X, Liu
CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-? (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation. GWAS Catalog
Clinical orthopaedics and related research 2019 May .
Wyles Cody C, Paradise Christopher R, Houdek Matthew T, Slager Susan L, Terzic Andre, Behfar Atta, van Wijnen Andre J, Sierra Rafael
CORR Insights®: CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor- ? (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
Clinical orthopaedics and related research 2019 Apr .
Goodman Stuart
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
Oral diseases 2020 Dec .
Van Poznak Catherine, Reynolds Evan L, Estilo Cherry L, Hu Mimi, Schneider Bryan Paul, Hertz Daniel L, Gersch Christina, Thibert Jacklyn, Thomas Dafydd, Banerjee Mousumi, Rae James M, Hayes Daniel
Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus. GWAS Catalog
Human molecular genetics 2021 Dec .
Suetsugu Hiroyuki, Kim Kwangwoo, Yamamoto Takuaki, Bang So-Young, Sakamoto Yuma, Shin Jung-Min, Sugano Nobuhiko, Kim Ji Soong, Mukai Masaya, Lee Yeon-Kyung, Ohmura Koichiro, Park Dae Jin, Takahashi Daisuke, Ahn Ga-Young, Karino Kohei, Kwon Young-Chang, Miyamura Tomoya, Kim Jihye, Nakamura Junichi, Motomura Goro, Kuroda Takeshi, Niiro Hiroaki, Miyamoto Takeshi, Takeuchi Tsutomu, Ikari Katsunori, Amano Koichi, Tada Yoshifumi, Yamaji Ken, Shimizu Masato, Atsumi Takashi, Seki Taisuke, Tanaka Yoshiya, Kubo Toshikazu, Hisada Ryo, Yoshioka Tomokazu, Yamazaki Mihoko, Kabata Tamon, Kajino Tomomichi, Ohta Yoichi, Okawa Takahiro, Naito Yohei, Kaneuji Ayumi, Yasunaga Yuji, Ohzono Kenji, Tomizuka Kohei, Koido Masaru, Matsuda Koichi, Okada Yukinori, Suzuki Akari, Kim Bong-Jo, Kochi Yuta, Lee Hye-Soon, Ikegawa Shiro, Bae Sang-Cheol, Terao Chikas
TOP